Press Release

Radiation Therapy Oncology Group (RTOG) Selects Visiontree Optimal Care (VTOC) as an Enterprise Solution for Collecting Quality of Life Patient Outcomes Data

Visiontree, the leader in Web-based patient-centered health data management, provider communication and integrated research systems, announced today that the Radiation Therapy Oncology Group (RTOG), selected the Visiontree Optimal Care (VTOC) platform as an enterprise solution for collecting Quality of Life (QOL) patient outcomes data.

Based on a pilot study in prostate cancer (RTOG 0828) at a select number of member institutions, RTOG will now offer all of its sites the ability to improve data collection, validation, and reporting processes through the use of Visiontree's oncology-specific, clinical research application. A head and neck study (RTOG 0920) will be the next to rollout, with all RTOG members given the opportunity to utilize the VTOC platform.

"Clinical research typically has a great challenge in consistently collecting patient-reported outcomes, since it is usually done through a paper or phone survey. VTOC offers us the ability to move this process to an electronic format through a secure Web portal to collect data in a faster and more compliant manner. The platform also allows us to deliver relevant information to the patient including reminders and study information more effectively. VTOC is a system whose time has come and we are pleased that it is making a difference in collecting long-term Quality of Life data that often goes missing."

Benjamin Movsas, M.D.
Chair of Radiation Oncology at Henry Ford Hospital Detroit and Principal Investigator of the 20-center RTOG 0828 study piloting the web-based, VTOC system

VTOC's user-friendly, HIPAA-secure, Web-based platform allows consenting patients to fill out their quality of life forms in real-time from any location that has Internet access, including their homes. The system can also send patients reminders via e-mail or text messaging to increase the likelihood of their on-going QOL participation. In clinical use for over seven years, VTOC is a user-friendly patient portal for collecting longitudinal data for cancer patients and deliver aggregate, de-identified data for research purposes on a multi-center, national scale.

"VTOC will be an important part of our quality of life data collection for head and neck cancer patients, and is expected to be used by many of the sites as a Web-based data collection option. Since many people are familiar and comfortable with Internet applications, we estimate that the system will provide us an increase in patient participation over the "paper and pencil" survey program that's in place now. That means the electronically collected quality of our data will be even more credible and usable."

Mitchell Machtay, M.D.
Principal Investigator of the RTOG 0920 study and Chairman of the Department of Radiation Oncology at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center

"VTOC is a win-win for both oncology patients and providers. The system empowers patients to provide important feedback directly with their physicians electronically, as well as build their own personal health records to help make the best decisions at the most critical times and provide a means of long-term communication for their care. VTOC is also serving as the vehicle to transform the healthcare ecosystem into a true paperless environment, increasing staff's productivity and data gathering capabilities to share patient-level data and effectively measure patient satisfaction. With more than 100 provider sites and 500,000 users, VTOC is providing a patient-centric solution for clinical trials participation and long-term care for oncology patients and their coordinated care team."

Martin Pellinat
CEO & Founder of Visiontree Software, Inc.

VTOC is fully compliant with Title 21, Part 11 of the Code of Federal Regulations (CFR) statistical process control system pertaining to electronic records and signatures.

About RTOG®

The Radiation Therapy Oncology Group (RTOG), located in the American College of Radiology (ACR) Clinical Research Center in Philadelphia, PA office. RTOG is a multi-institutional clinical cooperative group funded by the National Cancer Institute. RTOG has over 40 years of experience in conducting clinical trials and is comprised of over 350 major research institutions in the United States and Canada. The group currently is conducting more than 30 active studies that involve radiation therapy alone or in conjunction with surgery and/or chemotherapeutic drugs or which investigate quality of life issues and their effects on the cancer patient.

For more information, visit:

About Visiontree

Visiontree Software, Inc., a Brainlab company, is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The Visiontree Optimal Care (VTOC) outcomes platform is MACRA compliant as a modular EHR and implemented at over 600 sites with 2.5M+ patient records in 15+ languages.

The VTOC platform is used for multi-center research, registries and population health initiatives across multiple domains. Visiontree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 17 of the top 20 U.S. News and World Report hospitals.

Improve quality, safety and research

Learn more about how we can help